Insider Transactions in Q1 2021 at 89bio, Inc. (ETNB)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$168,000
$24.2 P/Share
|
|
Mar 16
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|
|
Feb 23
2021
|
Michael R Hayden |
BUY
Exercise of conversion of derivative security
|
Direct |
80,904
+24.39%
|
$161,808
$2.32 P/Share
|
|
Feb 16
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$161,000
$23.39 P/Share
|
|
Feb 16
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|
|
Feb 05
2021
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Feb 05
2021
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
|
Feb 05
2021
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Feb 05
2021
|
Ram Waisbourd Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
|
Feb 05
2021
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 19
2021
|
Ram Waisbourd Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$147,000
$21.16 P/Share
|
|
Jan 19
2021
|
Ram Waisbourd Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$7,000
$1.93 P/Share
|